Moderna’s total revenue for the third quarter still topped Wall Street’s expectations despite plummeting demand for its Covid-19 shot.

Was this article helpful?
YesNo

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Search Window